Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Given Consensus Rating of "Hold" by Brokerages
Market Beat·- Unicycive Therapeutics holds a consensus "Hold" rating from seven coverage firms, with 2 sell ratings and 5 buy ratings. - The company reported an EPS of ($0.06) for the quarter, beating analyst consensus estimates of ($0.47) by $0.41. - Institutional investors and hedge funds currently own 40.42 % of the company's stock, with a market capitalization of $147.63 million.